ALDH7A1 and cancer: Given that a number of PDE inhibitors are poised for repurposing and that statins have demonstrated anticancer activity in early‐phase clinical trials [42, 43, 44, 45, 46, 47, 48, 49], further studies are needed to evaluate the therapeutic benefit of a statin‐PDE inhibitor combination for the treatment of cancer.